| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/17/1997 | US5639728 Antineoplastic peptide |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639726 Peptide mediated enhancement of thrombolysis methods and compositions |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639664 A transformant; genetic engineering |
| 06/17/1997 | US5639661 Genes and proteins for treating cystic fibrosis |
| 06/17/1997 | US5639660 Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE |
| 06/17/1997 | US5639659 Process for inhibiting the growth of bacteria using bacteriocins produced by Propionibacterium jensenii strain ATCC 4872 |
| 06/17/1997 | US5639658 Split feed cell fermentation system |
| 06/17/1997 | US5639656 Antibodies reactive with biological markers of benign prostate hyperplasia |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639651 Gap-related gene, human IQGAP1 |
| 06/17/1997 | US5639650 cDNA clone for South African Arbovirus No. 86 |
| 06/17/1997 | US5639642 Synthetic leader peptide sequences |
| 06/17/1997 | US5639640 Polypeptide |
| 06/17/1997 | US5639639 Transforming a eukaryotic cell by inserting vector with dna coding for each of two subunits of hormone; culturing; expression |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639637 Pure protein free of blood products comprising a sequence of variant hepatitis b s protein, said protein comprising a modified a determinant of an s protein in which amino acid at position 145 is arginine |
| 06/17/1997 | US5639635 Process for bacterial production of polypeptides |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639619 Screening assay for anti-HIV drugs using the Vpr gene |
| 06/17/1997 | US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment |
| 06/17/1997 | US5639616 Isolated nucleic acid encoding a ubiquitous nuclear receptor |
| 06/17/1997 | US5639614 Isolated polynucleotide encoding mutant human sarcoplasmic reticulum calcium release channel; identification of genetic predisposition to specified cardiomyopathy |
| 06/17/1997 | US5639605 Human interleukin-3 receptor component |
| 06/17/1997 | US5639602 Using a dna probe |
| 06/17/1997 | US5639601 Synthetic peptide sequences useful in detection of foot and mouth disease |
| 06/17/1997 | US5639598 Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions |
| 06/17/1997 | US5639597 Specific, sensitive |
| 06/17/1997 | US5639594 Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| 06/17/1997 | US5639593 Method for determining TNF |
| 06/17/1997 | US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy |
| 06/17/1997 | US5639462 Attenuated polyiviruses vaccine containing them and vaccination methods using them |
| 06/17/1997 | US5639458 Class I MHC modulation of surface receptor activity |
| 06/17/1997 | US5639457 Introducing dna sequence coding for rearranged antibody into male pronucleus of fertilized ovum; implanting in pig or rabbit; transgenic offspring produce antibodies |
| 06/17/1997 | US5639454 Recombinant baculovirus with broad host range |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/17/1997 | US5639440 Administering mixture of polypeptide and immunogen to transgenic mammal having tolerance for polypeptide yields antibody capable of binding immunogen |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997021104A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | WO1997020943A1 Regulated protein expression in stably transfected mammalian cells |
| 06/12/1997 | WO1997020941A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 06/12/1997 | WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | WO1997020939A1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS |
| 06/12/1997 | WO1997020938A2 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 06/12/1997 | WO1997020934A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/12/1997 | WO1997020933A2 MUTATIONAL VARIANTS OF MAMMALIAN Ob GENE PROTEINS |
| 06/12/1997 | WO1997020931A1 Method and compositions for monitoring dna binding molecules in living cells |
| 06/12/1997 | WO1997020930A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 06/12/1997 | WO1997020929A1 Fibroblast growth factor fgf-10 |
| 06/12/1997 | WO1997020928A1 Novel semaphorin z and gene encoding the same |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020917A2 Dna encoding phage abortive infection protein from lactococcus lactis, and method of use thereof |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | WO1997020854A1 Recombinant gas vesicles and uses thereof |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020573A1 Growth factor receptor-binding protein 2 homolog |
| 06/12/1997 | WO1997020470A1 Regulation of plant development and physiology through plasmodesmatal macromolecular transport of proteins and oligonucleotides |
| 06/12/1997 | WO1997020468A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 06/12/1997 | WO1997020463A1 Controlled gene product delivery from a regulatable retroviral vector |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 06/12/1997 | WO1997011169A3 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 06/12/1997 | DE19547529A1 New monoclonal antibody specific for membrane antigen on colon carcinoma |
| 06/12/1997 | DE19545472A1 Diagnosis of squamous epithelial cell carcinoma |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2243508A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 06/12/1997 | CA2239951A1 Method and compositions for monitoring dna binding molecules in living cells |
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239728A1 Live attenuated vaccines based on cp45 hpiv-3 strain and method to ensure attenuation in such vaccines |
| 06/12/1997 | CA2239709A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239305A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2237494A1 Dna encoding phage abortive infection protein from lactococcus lactis, and method of use thereof |
| 06/12/1997 | CA2237181A1 Tissue factor - kunitz domain fusion proteins as factor viia inhibitors |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/11/1997 | EP0778347A2 ATP and nucleic acid-binding protein with putative helicase and ATPase characteristics |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777738A1 Condii toxoplasma p30 expression cassette |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777734A2 New polypetides having a toxic activity against insects of the dipter family |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777732A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/11/1997 | EP0777731A1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |